Search

everythinglearnresearchcommunity

for

Search:↓

Putting calcipotriol ointment on the skin once doesn't change calcium levels in the body right away.

Retinoids help treat psoriasis effectively, but they can cause side effects and need more research on safe use with other treatments.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Propolis and aloe vera ointment effectively treats mild to moderate psoriasis.

Narrowband UVB treatment increases certain gene expressions in psoriasis skin and improves symptoms.

Accidentally eating a topical steroid may rarely cause acute generalized pustular psoriasis.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Biologics for severe asthma have known side effects, but some new risks need more study.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

A boy with a rare skin condition improved quickly after starting zinc supplements.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Apremilast did not work for treating severe alopecia areata.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Platelet-rich plasma treatment may safely and effectively reduce skin lesions in psoriasis and atopic dermatitis.

Severe Hidradenitis Suppurativa increases missed and unproductive workdays.